BABA vs JEM

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

JEM exhibits a Piotroski F-Score of 4/9, indicating a stable but mediocre financial health baseline, yet this is overshadowed by catastrophic price performance and operational failure. The company has suffered a 97.1% decline over the last year, crashing from a 52-week high of $158.00 to $0.11. While the balance sheet shows low leverage (Debt/Equity 0.08) and decent liquidity (Current Ratio 2.81), the core business is hemorrhaging cash with an operating margin of -71.57% and a devastating ROE of -133.41%. The lack of an Altman Z-Score and Graham Number reflects the absence of positive earnings, rendering traditional value metrics inapplicable.